Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bevon is a comprehensive multivitamin, multimineral, and antioxidant nutritional supplement developed and marketed by Zuventus Healthcare. It is formulated to address vitamin and mineral deficiency states and provide nutritional support for general health, immunity, and chronic conditions such as cardiovascular diseases, diabetes, and atherosclerosis. The product contains a wide array of B vitamins (including pyridoxine, niacinamide, cyanocobalamin, folic acid, and biotin), essential minerals (such as zinc, selenium, copper, chromium, manganese, molybdenum, vanadium, boron, nickel, and phosphorus), and antioxidants like beta-carotene. Bevon is available in multiple formulations, including capsules, liquid suspensions, and drops, as well as a specialized variant, Bevon CD, tailored for cardiovascular and diabetic support. It is a leading multivitamin brand in India, where it is approved and marketed for general wellness and as an adjunct in managing age-related and metabolic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bevon.